Latest news
Structure Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 20:14:34 GMTAscletis Announces Initiation of Global Phase III for Oral Small Molecule GLP-1, ASC30 and Positive Preclinical Data for Its First-in-Class Oral Small Molecule GLP-1/GIP/Amylin Fixed-Dose Combination - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 10:55:00 GMT